Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
1.
Infect Genet Evol ; 91: 104816, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33771725

RESUMEN

This study is focused on genome sequence and annotation of the Bacteroides strain isolated from the blood of a patient with descending colon cancer. According to a comparison of the 16S ribosomal RNA sequence with the National Center for Biotechnology Information database, this strain was identified as Bacteroides sp. aff. Thetaiotaomicron. The next-generation sequencing of the strain was performed in a GENEWIZ laboratory (Jiangsu, China) on Illumina HiSeq device. According to CAZy classification, metabolic pathways related to carbohydrate metabolism of this strain engage the following enzymes: 427 glycosylhydrolases, 277 glycosyltransferases, 137 carbohydrate-binding modules, 48 carbohydrate esterases, and 24 polysaccharide lyases. According to the KEGG pathway database, Bacteroides sp. aff thetaiotaomicron strain is reported to incorporate 199 pathway associated genes. Bacteroides sp. aff. Thetaiotaomicron exposes the capacity of metabolizing a variety of polysaccharides. Its genome is enriched with an expanded repertoire of enzymes for the hydrolysis of glycosidic bonds and, thus, likely to hydrolyze most of glycosidic bonds in biological polysaccharides. The advanced capabilities of the studied strain to recognize and respond to environmental signals are expressed in the rich representation of one- and two-component signal transduction systems.


Asunto(s)
Infecciones por Bacteroides/sangre , Bacteroides thetaiotaomicron/genética , Metabolismo de los Hidratos de Carbono/genética , Genoma Bacteriano , Bacteroides thetaiotaomicron/enzimología , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Persona de Mediana Edad , ARN Bacteriano/análisis , ARN Ribosómico 16S/análisis
2.
Clin Lab ; 65(12)2019 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-31850719

RESUMEN

BACKGROUND: Bacteroides caccae is a ubiquitous, anaerobic bacteria, but it is not a common cause of pathologic bloodstream infection. Diabetic patients are at increased risk of developing anaerobic bacteria infection. Here, we report a repeated fever case caused by Bacteroides caccae in a diabetic patient. The aim of this study was to describe the clinical characteristics and manifestations of Bacteroides caccae. METHODS: The pathogenic bacteria isolated from patient blood was identified as Bacteroides caccae. Identification of the Bacteroides caccae was done by 16s rDNA sequencing and matrix-assisted laser desorption/ionization-time of light spectrometry. The infection was cured by one-week combined therapy of intravenous Piperacillin tazobactam and oral Ornidazole tablet. RESULTS: After treatment had been completed, no episodes of fever occurred during the follow-up to date. CONCLUSIONS: Bacteroides caccae is regarded as an intestinal, opportunistic pathogenic bacteria. It can invade the mucosa of the intestine and cause various abdominal suppurative infections. Sequencing and matrix-assisted laser desorption/ionization-time of flight spectrometry could have a role for Bacteroides caccae diagnosis. The curative effect of using first generation cephalosporines therapy was unsatisfactory. Using intravenous Piperacillin tazobactam and ornidazole tablet might obtain certain curative effect. Early diagnosis and appropriate anti-infection therapy were necessary to improve the outcome of patients with Bacteroides caccae bloodstream infection.


Asunto(s)
Infecciones por Bacteroides/microbiología , Bacteroides/fisiología , Complicaciones de la Diabetes/microbiología , Diabetes Mellitus/microbiología , Fiebre/microbiología , Bacteroides/efectos de los fármacos , Bacteroides/aislamiento & purificación , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/tratamiento farmacológico , Complicaciones de la Diabetes/sangre , Complicaciones de la Diabetes/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Fiebre/tratamiento farmacológico , Humanos , Persona de Mediana Edad , Ornidazol/uso terapéutico , Combinación Piperacilina y Tazobactam/uso terapéutico
4.
J Immunol ; 195(5): 2231-40, 2015 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-26209620

RESUMEN

Recent reports focusing on virulence factors of periodontal pathogens implicated proteinases as major determinants of remarkable pathogenicity of these species, with special emphasis on their capacity to modulate complement activity. In particular, bacteria-mediated cleavage of C5 and subsequent release of C5a seems to be an important phenomenon in the manipulation of the local inflammatory response in periodontitis. In this study, we present mirolysin, a novel metalloproteinase secreted by Tannerella forsythia, a well-recognized pathogen strongly associated with periodontitis. Mirolysin exhibited a strong effect on all complement pathways. It inhibited the classical and lectin complement pathways due to efficient degradation of mannose-binding lectin, ficolin-2, ficolin-3, and C4, whereas inhibition of the alternative pathway was caused by degradation of C5. This specificity toward complement largely resembled the activity of a previously characterized metalloproteinase of T. forsythia, karilysin. Interestingly, mirolysin released the biologically active C5a peptide in human plasma and induced migration of neutrophils. Importantly, we demonstrated that combination of mirolysin with karilysin, as well as a cysteine proteinase of another periodontal pathogen, Prevotella intermedia, resulted in a strong synergistic effect on complement. Furthermore, mutant strains of T. forsythia, devoid of either mirolysin or karilysin, showed diminished survival in human serum, providing further evidence for the synergistic inactivation of complement by these metalloproteinases. Taken together, our findings on interactions of mirolysin with complement significantly add to the understanding of immune evasion strategies of T. forsythia and expand the knowledge on molecular mechanisms driving pathogenic events in the infected periodontium.


Asunto(s)
Proteínas Bacterianas/inmunología , Infecciones por Bacteroides/inmunología , Bacteroides/inmunología , Activación de Complemento/inmunología , Proteínas del Sistema Complemento/inmunología , Metaloproteasas/inmunología , Periodontitis/inmunología , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Bacteroides/genética , Bacteroides/fisiología , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/microbiología , Movimiento Celular/inmunología , Vía Alternativa del Complemento/inmunología , Vía Clásica del Complemento/inmunología , Lectina de Unión a Manosa de la Vía del Complemento/inmunología , Hemólisis/inmunología , Interacciones Huésped-Patógeno/inmunología , Humanos , Metaloproteinasas de la Matriz/genética , Metaloproteinasas de la Matriz/inmunología , Metaloproteinasas de la Matriz/metabolismo , Metaloproteasas/genética , Metaloproteasas/metabolismo , Viabilidad Microbiana/genética , Viabilidad Microbiana/inmunología , Mutación , Neutrófilos/inmunología , Neutrófilos/metabolismo , Periodontitis/sangre , Periodontitis/microbiología , Ovinos
5.
Emerg Infect Dis ; 21(1): 95-8, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25529016

RESUMEN

Metronidazole- and carbapenem-resistant Bacteroides fragilis are rare in the United States. We isolated a multidrug-resistant anaerobe from the bloodstream and intraabdominal abscesses of a patient who had traveled to India. Whole-genome sequencing identified the organism as a novel Bacteroides genomospecies. Physicians should be aware of the possibility for concomitant carbapenem- and metronidazole-resistant Bacteroides infections.


Asunto(s)
Infecciones por Bacteroides/microbiología , Bacteroides/efectos de los fármacos , Adenocarcinoma/sangre , Adenocarcinoma/microbiología , Adenocarcinoma/secundario , Anciano , Antibacterianos/farmacología , Bacteroides/genética , Bacteroides/aislamiento & purificación , Infecciones por Bacteroides/sangre , Neoplasias del Colon/sangre , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Farmacorresistencia Bacteriana Múltiple , Genoma Bacteriano , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Análisis de Secuencia de ADN
6.
Anaerobe ; 17(4): 152-5, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21376821

RESUMEN

This report summarizes the case of a 23 year-old otherwise healthy male that was injured in an improvised explosive device (IED) blast in support of Operation Enduring Freedom (OEF). He sustained bilateral open tibia and fibula fractures in the setting of being exposed to water contaminated with raw sewage. Despite long-term carbapenem therapy, the patient's wounds were repeatedly noted to have purulent drainage during surgical debridement and cultures from these wounds were persistently positive for Bacteroides fragilis. Apparent clinical failure persisted despite the addition of metronidazole to his regimen and an eventual trial of tigecycline. Susceptibility testing of the B. fragilis isolate was performed and resistance to penicillin, clindamycin,metronidazole, cefoxitin, meropenem, imipenem, piperacillin/tazobactam, and tigecycline was confirmed. The presence of a nimE gene on a potentially transferrable plasmid was also confirmed by plasmid sequencing. The only antibiotics that displayed in vitro susceptibility were moxifloxacin and linezolid. These antibiotics were initiated in combination with aggressive irrigation and serial surgical debridement. Conversion to left-sided internal fixation became feasible and his left lower extremity was salvaged without residual evidence of infection. The patient completed an eight week course of combination moxifloxacin and linezolid therapy without adverse event. This B. fragilis isolate displayed simultaneous high-level resistance to multiple antibiotics routinely utilized in anaerobic infections. This was evidenced by clinical failure, in vitro susceptibility testing, and demonstration of genes associated with resistance mechanisms. This case warrants review not only due to the rarity of this event but also the potential implications regarding anaerobic infections in traumatic wounds and the success of a novel treatment regimen utilizing combination therapy with moxifloxacin and linezolid.


Asunto(s)
Infecciones por Bacteroides/microbiología , Bacteroides fragilis/efectos de los fármacos , Traumatismos por Explosión/microbiología , Traumatismos de la Pierna/microbiología , Campaña Afgana 2001- , Afganistán , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Infecciones por Bacteroides/sangre , Bacteroides fragilis/genética , Bacteroides fragilis/aislamiento & purificación , Traumatismos por Explosión/sangre , Farmacorresistencia Bacteriana Múltiple , Genes Bacterianos , Humanos , Masculino , Pruebas de Sensibilidad Microbiana/métodos , Adulto Joven
8.
Curr Microbiol ; 55(4): 362-5, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17882508

RESUMEN

This study investigated whether B. fragilis from various human sites acquired stable traits enabling it to express certain efflux pumps (EPs), adopt a particular cell structure, and tolerate certain stressors. Isolates from blood, abscess, and stool (n = 11 each) were investigated. Bacteria from various sites portrayed different ultrastructres and EP expression. Blood isolates were tolerant to nutrient limitation and stool isolates to NaCl and bile salt stress. Stressors significantly increased EP expression. These data demonstrate that (1) B. fragilis acquires stable traits from various in vivo microenvironments; (2) that EPs are involved in stress responsiveness; and (3) that EP expression is tightly controlled and site dependent.


Asunto(s)
Infecciones por Bacteroides/microbiología , Bacteroides fragilis/fisiología , Absceso/microbiología , Proteínas Bacterianas/metabolismo , Infecciones por Bacteroides/sangre , Bacteroides fragilis/crecimiento & desarrollo , Bacteroides fragilis/ultraestructura , Regulación Bacteriana de la Expresión Génica , Humanos , Proteínas de Transporte de Membrana/metabolismo , Microscopía Electrónica de Transmisión
9.
Braz J Med Biol Res ; 40(3): 317-22, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17334528

RESUMEN

Sepsis, the leading cause of death in intensive care units, is associated with overproduction of nitric oxide (NO) due to inducible NO synthase (iNOS), responsible for some of the pathologic changes. Aminoguanidine (AG) is a selective iNOS inhibitor with reported inconsistent actions in sepsis. To investigate the influence of iNOS, we studied models of acute bacterial sepsis using acute challenges with aerobic (Escherichia coli) and anaerobic (Bacteroides fragilis) bacteria in the presence of AG. Six-week-old, 23 g, male and female BALB/c and C57Bl/6j mice, in equal proportions, were inoculated (ip) with bacteria in groups of 4 animals for each dose and each experiment in the absence or presence of AG (50 mg/kg, ip, starting 24 h before challenge and daily until day 6) and serum nitrate was measured by chemiluminescence. Both types of bacteria were lethal to mice, with an LD50 of 6 nephelometric units (U) for E. coli and 8 U for B. fragilis. Nitrate production peaked on the second day after E. coli inoculation with 8 and 6 U (P < 0.05), but was absent after non-lethal lower doses. After challenge with B. fragilis this early peak occurred at all tested doses after 24 h, including non-lethal ones (P < 0.05). AG-treated mice challenged with E. coli presented higher survival (P < 0.05) and increased LD50. AG-treated mice challenged with B. fragilis had lower LD50 and higher mortality. Control AG-treated animals presented no toxic effects. The opposite effect of iNOS blockade by AG in these models could be explained by restriction of oxygen for immune cells or an efficient action of NO in anaerobic localized infections. The antagonic role of NO production observed in our bacterial models could explain the reported discrepancy of NO action in sepsis.


Asunto(s)
Infecciones por Bacteroides/tratamiento farmacológico , Infecciones por Escherichia coli/tratamiento farmacológico , Guanidinas/uso terapéutico , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico/biosíntesis , Sepsis/tratamiento farmacológico , Enfermedad Aguda , Animales , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/mortalidad , Bacteroides fragilis , Modelos Animales de Enfermedad , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/mortalidad , Femenino , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Nitratos/sangre , Sepsis/sangre , Sepsis/microbiología , Sepsis/mortalidad , Tasa de Supervivencia
10.
Am J Surg ; 186(5): 519-25, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14599618

RESUMEN

BACKGROUND: A clinical hallmark of sepsis is an early, hyperdynamic cardiac phase (increased cardiac output) that degrades to a hypodynamic phase, which results in poor gut perfusion and subsequent gastrointestinal (GI) hypoxemia, tissue ischemia, necrosis and loss of gut barrier function. Studies in rat cecal-ligation and puncture suggest that the potent vasodilator adrenomedullin (AM) might initiate or maintain the hypodynamic phase. We hypothesize that AM expression is increased in acute Escherichia coli bacteremia and chronic E coli-Bacteroides fragilis sepsis. METHODS: Acute bacteremia: male Sprague-Dawley rats were anesthetized (urethane/alpha-chloralose), tracheotomized, and cannulated for monitoring blood pressure (MABP) and heart rate (HR) and for infusion of E coli (10(9) colony-forming units [CFU] E coli per 1 mL normal saline) and blood sampling. Arterial blood was withdrawn for arterial blood gas (ABG) measurements every 60 minutes. After 6 hours, we harvested lung, liver, kidney, spleen, and small intestine tissue samples and drew arterial and portal blood for AM enzyme-linked immunosorbent assay (ELISA). Chronic sepsis: a sterile gauze pad was implanted and animals recovered for 5 days. Twenty-four hours (10(9) CFU E coli and 10(9) CFU B fragilis per 1 mL normal saline; 1 injection) or 72 hours (2 injections) after the inoculation of the back sponge, rats were anesthetized, intubated, and cannulated as above. MABP, HR, and ABG were measured for 1 hour before tissue and serum harvest for AM ELISA. RESULTS: Sepsis increased HR and MABP in all groups. Acute sepsis caused a respiratory alkalosis and pH was also elevated in chronic sepsis. Serum AM levels were increased in all groups compared with baseline and remained elevated at every time point, but were not different between saline controls and septic animals at any time point, except for the portal serum from the 72-hour chronic sepsis, which was elevated. CONCLUSIONS: These data suggest that surgical manipulation alone is sufficient to stimulate AM secretion, most probably from endothelial cells. While the AM levels were decreasing at 72 hours compared with 6 hours or 24 hours in the arterial blood and the saline control portal blood, it remained elevated in the septic portal samples, suggesting that the sepsis-induced increase of AM was derived from the gut by a different mechanism than that which elevated arterial serum levels.


Asunto(s)
Péptidos/sangre , Sistema Porta/metabolismo , Choque Séptico/sangre , Vasodilatadores/sangre , Enfermedad Aguda , Adrenomedulina , Animales , Bacteriemia/sangre , Infecciones por Bacteroides/sangre , Bacteroides fragilis , Enfermedad Crónica , Ensayo de Inmunoadsorción Enzimática , Infecciones por Escherichia coli/sangre , Masculino , Insuficiencia Multiorgánica/sangre , Insuficiencia Multiorgánica/etiología , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
11.
Am J Med Sci ; 325(6): 365-8, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12811233

RESUMEN

Infections with Bacteroides species have been noted to occur in association with cases of thrombophlebitis. This association has led to the speculation that the microorganisms themselves may contribute to the pathogenesis of thrombus formation through elaborated enzymes, including heparinases, or by interactions between the clotting cascade and the unique structure of the Bacteroides lipopolysaccharide. Anti-phospholipid antibodies have been linked with hypercoagulable states and thrombus formation. Although a number of infections have been associated with the transient production of anti-cardiolipin antibodies, the effect the antibodies may have in contributing to thrombus formation is not well understood. The occurrence of Bacteroides species infection with transient anti-cardiolipin antibody has not been previously reported.


Asunto(s)
Anticuerpos Anticardiolipina/sangre , Infecciones por Bacteroides/diagnóstico , Flebitis/sangre , Vena Porta , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/complicaciones , Infecciones por Bacteroides/patología , Humanos , Masculino , Persona de Mediana Edad , Flebitis/complicaciones , Flebitis/diagnóstico , Flebitis/patología
12.
Antimicrob Agents Chemother ; 47(1): 148-53, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12499183

RESUMEN

A retrospective analysis of susceptibility data on 542 blood isolates of the Bacteroides fragilis group tested from 1987 to 1999 by the same NCCLS-recommended broth microdilution method throughout is presented. Metronidazole, beta-lactam-beta-lactamase inhibitor combinations, carbapenems, and trovafloxacin were the most active agents (susceptibility of >or=93%). Among the cephalosporin-cephamycins, the order of activity was cefoxitin > ceftizoxime > cefotetan = cefotaxime = cefmetazole > ceftriaxone. All isolates were resistant to penicillin G, and 22% were resistant to clindamycin. The susceptibility rates to piperacillin-tazobactam, imipenem, and meropenem were affected least among isolates resistant to cefoxitin or clindamycin. Except for piperacillin-tazobactam, imipenem, and meropenem, the B. fragilis species was more susceptible than were the non-B. fragilis species. These data underscore the importance of susceptibility testing of the B. fragilis group and can serve as a guide in the choice of empirical antimicrobial therapy.


Asunto(s)
Antibacterianos/farmacología , Infecciones por Bacteroides/enzimología , Bacteroides fragilis/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , beta-Lactamasas/biosíntesis , Infecciones por Bacteroides/sangre , Bacteroides fragilis/aislamiento & purificación , Humanos
13.
Afr J Med Med Sci ; 29(3-4): 207-10, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11713990

RESUMEN

In a study of 100 patients in Ibadan between July and December 1995 to evaluate bacteraemia due to gram-negative bacilli, 64% were culture positive, 44 (68.8%) of these yielded gram-negative rods. The isolates were Klebsiella species (43.2%), Escherichia coli (27.3%), Pseudomonas aeruginosa (13.6%), Proteus species (11.4%) and Bacteroides melaninogenious (4.15%) by standard bacteriological methods. Antimicrobial sensitivity results suggested ofloxacin or ceftriaxone with metronidazole as empirical antibiotic therapy.


Asunto(s)
Bacteriemia/epidemiología , Bacteriemia/etiología , Infecciones por Bacteroides/epidemiología , Infecciones por Bacteroides/etiología , Diabetes Mellitus Tipo 2/complicaciones , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/etiología , Infecciones por Klebsiella/epidemiología , Infecciones por Klebsiella/etiología , Infecciones por Proteus/epidemiología , Infecciones por Proteus/etiología , Infecciones por Pseudomonas/epidemiología , Infecciones por Pseudomonas/etiología , Salud Urbana/estadística & datos numéricos , Distribución por Edad , Anciano , Antibacterianos/uso terapéutico , Bacteriemia/sangre , Bacteriemia/tratamiento farmacológico , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/tratamiento farmacológico , Resistencia a Medicamentos , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/tratamiento farmacológico , Femenino , Hospitales Universitarios , Humanos , Infecciones por Klebsiella/sangre , Infecciones por Klebsiella/tratamiento farmacológico , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Nigeria/epidemiología , Servicio Ambulatorio en Hospital , Selección de Paciente , Vigilancia de la Población , Prevalencia , Infecciones por Proteus/sangre , Infecciones por Proteus/tratamiento farmacológico , Infecciones por Pseudomonas/sangre , Infecciones por Pseudomonas/tratamiento farmacológico , Distribución por Sexo
15.
J Surg Res ; 80(1): 44-51, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9790813

RESUMEN

BACKGROUND: Hyperlactatemia is a metabolic complication of hypermetabolic, hyperdynamic sepsis. An important mechanism responsible for elevating plasma lactate concentrations in sepsis is altered regulation of the pyruvate dehydrogenase complex (PDH) in skeletal muscle. We investigated the ability of a specific tumor necrosis factor binding protein, TNFbp, to modulate lactate concentrations and skeletal muscle PDH activity in a rodent model of chronic abdominal sepsis. MATERIALS AND METHODS: We examined the regulation of lactate metabolism in four groups of animals: Control, Control + TNFbp, Septic, and Septic + TNFbp. Chronic (5 days) sepsis was induced by the creation of a stable intraabdominal abscess using a sterile fecal-agar pellet inoculated with E. coli plus B. Fragilis as the foreign body nidus. TNFbp (1 mg/kg/day) was injected subcutaneously daily. RESULTS: Sepsis increased plasma and skeletal muscle lactate concentrations 2-fold compared with control. In septic rats treated with TNFbp, plasma and skeletal muscle lactate concentrations were significantly decreased compared with untreated septic rats. In skeletal muscle, sepsis resulted in a 70% decrease in the proportion of the PDH in the active form compared with controls. The sepsis-induced inhibition in the PDH complex activity was prevented by TNFbp. PDH kinase was enhanced 1.8-fold in sepsis, and the increase in PDH kinase activity was prevented by treatment with TNFbp. TNFbp treatment did not have any effects on plasma lactate or the proportion of active skeletal muscle PDH activity in control animals. CONCLUSIONS: TNFbp prevents the sepsis-induced hyperlactatemia and derangements in skeletal muscle lactate concentrations and PDH activity. These observations suggest that TNF is an important mediator responsible for lactate dyshomeostasis during sepsis.


Asunto(s)
Infecciones Bacterianas/metabolismo , Ácido Láctico/sangre , Músculo Esquelético/metabolismo , Proteínas Quinasas/metabolismo , Receptores del Factor de Necrosis Tumoral/fisiología , Abdomen/microbiología , Animales , Infecciones Bacterianas/sangre , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/metabolismo , Bacteroides fragilis , Activación Enzimática/fisiología , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/metabolismo , Masculino , Proteínas Serina-Treonina Quinasas , Piruvato Deshidrogenasa Quinasa Acetil-Transferidora , Ratas , Ratas Sprague-Dawley , Receptores Tipo I de Factores de Necrosis Tumoral , Receptores Señuelo del Factor de Necrosis Tumoral
16.
Antimicrob Agents Chemother ; 41(9): 1933-6, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9303387

RESUMEN

We investigated the efficacy of trovafloxacin, a new quinolone, in comparison with that of clindamycin in the treatment of intra-abdominal abscesses caused by Bacteroides fragilis in young and senescent mice. The development of abscess formation, the number of viable organisms, and antibiotic concentrations were measured, and the values for young and old mice were compared. Trovafloxacin was well distributed to the tissues in both young and old animals. Although the pharmacokinetics and concentrations of trovafloxacin in serum were similar between young and old mice, the levels in tissue were higher in senescent mice than in young mice. Trovafloxacin therapy sterilized abscesses in 94% of young mice and in 73% of old mice, but this difference was not significant. This therapeutic response to trovafloxacin was similar to that seen with clindamycin. These results suggest that aging may not have any adverse effect on the therapeutic outcome for intra-abdominal abscesses caused by B. fragilis.


Asunto(s)
Absceso Abdominal/tratamiento farmacológico , Envejecimiento/fisiología , Antiinfecciosos/farmacología , Infecciones por Bacteroides/tratamiento farmacológico , Fluoroquinolonas , Naftiridinas/farmacología , Absceso Abdominal/sangre , Absceso Abdominal/metabolismo , Envejecimiento/sangre , Envejecimiento/metabolismo , Animales , Antibacterianos/farmacología , Antiinfecciosos/sangre , Antiinfecciosos/farmacocinética , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/metabolismo , Clindamicina/farmacología , Masculino , Ratones , Naftiridinas/sangre , Naftiridinas/farmacocinética , Distribución Tisular
17.
FEMS Immunol Med Microbiol ; 17(2): 79-86, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9061353

RESUMEN

We investigated the effect of succinic acid on neutrophil bactericidal activity in a model of intra-abdominal abscess induced in mice by the peritoneal inoculation of 5 x 10(6) cfu ml-1 E. coli and 5 x 10(8) cfu ml-1 B. fragilis plus 1 mg of bran as faecal fibre analogue. The mean pH of the induced abscesses at week 1 was 6.7, higher than the pH associated with succinic acid inhibitory activity. We therefore determined the effect of succinic acid (0-100 mM) at pH 6.7 on the bactericidal activity of mouse bone marrow-derived neutrophils. Phagocytic killing of Proteus mirabilis by neutrophils was significantly inhibited by 30-100 mM succinic acid at pH 6.7 but there was no significant effect of succinic acid on engulfment of bacteria at this pH. However, significant inhibition of intracellular killing (assayed by adding succinic acid to suspensions of neutrophils which had engulfed bacteria in low serum concentrations but in the absence of succinic acid) was noted at 70 and 100 mM. These results indicate that succinic acid inhibits neutrophil bactericidal activity at a physiological pH, principally through inhibition of intracellular killing mechanisms and therefore contributing to bacterial persistence in this model of abscess formation.


Asunto(s)
Bacteroides fragilis/química , Actividad Bactericida de la Sangre/efectos de los fármacos , Escherichia coli/química , Neutrófilos/efectos de los fármacos , Neutrófilos/microbiología , Succinatos/farmacología , Absceso Abdominal/sangre , Absceso Abdominal/inmunología , Absceso Abdominal/microbiología , Animales , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/inmunología , Bacteroides fragilis/efectos de los fármacos , Antígenos CD11/biosíntesis , Antígenos CD11/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/inmunología , Concentración de Iones de Hidrógeno , Masculino , Ratones , Ratones Endogámicos BALB C , Fagocitosis/efectos de los fármacos , Infecciones por Proteus/sangre , Infecciones por Proteus/inmunología , Ácido Succínico
18.
Am Surg ; 61(6): 521-5, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7762902

RESUMEN

Intra-abdominal abscess is seldom adequately treated by systemic antibiotics alone and often requires surgical or computed tomography-guided drainage for resolution. Abscess penetration of six currently used antibiotics was examined in a murine intra-abdominal abscess model. Ampicillin/sulbactam, cefmetazole, clindamycin, and trospectomycin penetrated intra-abdominal abscesses to a greater degree than cefoxitin and ceftriaxone. Abscess pus antibiotic levels were not significantly higher after multiple doses than after a single dose. Pus antibiotic levels below the MIC90 for Bacteroides and E. coli within intra-abdominal abscess were observed for most antibiotics with the doses used in this study. Selection of antibiotics with a greater ability to penetrate abscess may be important in optimally treating patients with abdominal infection.


Asunto(s)
Absceso Abdominal/tratamiento farmacológico , Antibacterianos/farmacocinética , Absceso Abdominal/sangre , Ampicilina/farmacocinética , Ampicilina/uso terapéutico , Animales , Antibacterianos/sangre , Antibacterianos/uso terapéutico , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/tratamiento farmacológico , Bacteroides fragilis , Cefmetazol/farmacocinética , Cefmetazol/uso terapéutico , Cefoxitina/farmacocinética , Cefoxitina/uso terapéutico , Ceftriaxona/farmacocinética , Ceftriaxona/uso terapéutico , Clindamicina/farmacocinética , Clindamicina/uso terapéutico , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada/farmacocinética , Quimioterapia Combinada/uso terapéutico , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/tratamiento farmacológico , Concentración de Iones de Hidrógeno , Masculino , Ratones , Pruebas de Sensibilidad Microbiana , Espectinomicina/análogos & derivados , Espectinomicina/farmacocinética , Espectinomicina/uso terapéutico , Sulbactam/farmacocinética , Sulbactam/uso terapéutico
20.
J Reprod Med ; 38(9): 719-24, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8254596

RESUMEN

Previous animal experiments utilizing bowel flora have demonstrated synergy between various aerobes and anaerobes in the formation of intraabdominal abscesses. In these experiments, human female genital tract isolates were inserted into the abdominal and pelvic cavities of 151 female Sprague-Dawley rats. Inoculation with any single species of organism--Streptococcus faecalis, Enterobacter cloacae or Bacteroides bivius or a combination of two facultative organisms (S faecalis plus E cloacae)--did not result in a significant increase in abscess formation. Combination of a facultative organism or organisms with the anaerobe B bivius or S faecalis plus B bivius plus E cloacae resulted in 55% (P < .01) and 74% (P < .0005) rates of abscess formation, respectively, as compared with controls. Combinations including B fragilis demonstrated similar results. Thus, female genital tract facultative organisms demonstrate synergy in the presence of anaerobic organisms in the development of abscesses.


Asunto(s)
Absceso/microbiología , Infecciones por Bacteroides/microbiología , Modelos Animales de Enfermedad , Enterobacter cloacae , Infecciones por Enterobacteriaceae/microbiología , Enterococcus faecalis , Enfermedades de los Genitales Femeninos/microbiología , Infecciones por Bacterias Grampositivas/microbiología , Absceso/sangre , Absceso/epidemiología , Animales , Infecciones por Bacteroides/sangre , Infecciones por Bacteroides/epidemiología , Comorbilidad , Enterobacter cloacae/aislamiento & purificación , Enterobacter cloacae/patogenicidad , Infecciones por Enterobacteriaceae/sangre , Infecciones por Enterobacteriaceae/epidemiología , Enterococcus faecalis/aislamiento & purificación , Enterococcus faecalis/patogenicidad , Femenino , Enfermedades de los Genitales Femeninos/sangre , Enfermedades de los Genitales Femeninos/epidemiología , Infecciones por Bacterias Grampositivas/sangre , Infecciones por Bacterias Grampositivas/epidemiología , Incidencia , Ratas , Ratas Sprague-Dawley , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...